Ask AI
ProCE Banner Activity

VICONEL: Dolutegravir Resistance Among People Living With Detectable HIV-1 RNA

Conference Coverage
Slideset

Using data from this nested cohort in Lesotho, investigators identified the rate and patterns of DTG resistance in people with repeated detectable HIV-1 RNA and previous genotypic resistance testing. 

Released: November 17, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions